Abstract
Owing to their high spatiotemporal precision and adaptability to different host cells, organ-on-a-chip systems are showing great promise in drug discovery, developmental biology studies and disease modeling. However, many current micro-engineered biomimetic systems are limited in technological application because of culture media mixing that does not allow direct incorporation of techniques from stem cell biology, such as organoids. Here, we describe a detailed alternative method to cultivate millimeter-scale functional vascularized tissues on a biofabricated platform, termed ‘integrated vasculature for assessing dynamic events’, that enables facile incorporation of organoid technology. Utilizing the 3D stamping technique with a synthetic polymeric elastomer, a scaffold termed ‘AngioTube’ is generated with a central microchannel that has the mechanical stability to support a perfusable vascular system and the self-assembly of various parenchymal tissues. We demonstrate an increase in user familiarity and content analysis by situating the scaffold on a footprint of a 96-well plate. Uniquely, the platform can be used for facile connection of two or more tissue compartments in series through a common vasculature. Built-in micropores enable the studies of cell invasion involved in both angiogenesis and metastasis. We describe how this protocol can be applied to create both vascularized cardiac and hepatic tissues, metastatic breast cancer tissue and personalized pancreatic cancer tissue through incorporation of patient-derived organoids. Platform assembly to populating the scaffold with cells of interest into perfusable functional vascularized tissue will require 12–14 d and an additional 4 d if pre-polymer and master molds are needed.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data presented in this paper are available from the original references, the source data files supplied with this publication and the corresponding author. Source data are provided with this paper.
References
DiMasi, J. A., Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20–33 (2016).
Kinch, M. S. & Merkel, J. An analysis of FDA-approved drugs for inflammation and autoimmune diseases. Drug Discov. Today 20, 920–923 (2015).
Ben-David, U. et al. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat. Genet. 49, 1567–1575 (2017).
Cekanova, M. & Rathore, K. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des. Devel. Ther. 8, 1911–1921 (2014).
Danhof, M., de Lange, E. C., Della Pasqua, O. E., Ploeger, B. A. & Voskuyl, R. A. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. Trends Pharmacol. Sci. 29, 186–191 (2008).
Dahan, A., Beig, A., Lindley, D. & Miller, J. M. The solubility-permeability interplay and oral drug formulation design: two heads are better than one. Adv. Drug Deliv. Rev. 101, 99–107 (2016).
Ghane Shahrbaf, F. & Assadi, F. Drug-induced renal disorders. J. Renal Inj. Prev. 4, 57–60 (2015).
Wu, H. & Huang, J. Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies. Curr. Drug Metab. 19, 559–567 (2018).
Sorrentino, M. F., Kim, J., Foderaro, A. E. & Truesdell, A. G. 5-fluorouracil induced cardiotoxicity: review of the literature. Cardiol. J. 19, 453–458 (2012).
Deavall, D. G., Martin, E. A., Horner, J. M. & Roberts, R. Drug-induced oxidative stress and toxicity. J. Toxicol. 2012, 645460 (2012).
Yamanaka, S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10, 678–684 (2012).
Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407–418 (2018).
Fatehullah, A., Tan, S. H. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246–254 (2016).
Dutta, D., Heo, I. & Clevers, H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol. Med. 23, 393–410 (2017).
Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010).
Huh, D. et al. Microfabrication of human organs-on-chips. Nat. Protoc. 8, 2135–2157 (2013).
Esch, E. W., Bahinski, A. & Huh, D. Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 14, 248–260 (2015).
Zhang, B., Korolj, A., Lai, B. F. L. & Radisic, M. Advances in organ-on-a-chip engineering. Nat. Rev. Mater. 3, 257–278 (2018).
Jo, B.-H., Van Lerberghe, L. M., Motsegood, K. M. & Beebe, D. J. Three-dimensional micro-channel fabrication in polydimethylsiloxane (PDMS) elastomer. J. Microelectromech. Syst. 9, 76–81 (2000).
Berthier, E., Young, E. W. & Beebe, D. Engineers are from PDMS-land, biologists are from Polystyrenia. Lab Chip 12, 1224–1237 (2012).
van Meer, B. J. et al. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem. Biophys. Res. Commun. 482, 323–328 (2017).
Zhang, B. et al. Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surfical anastomosis. Nat. Mater. 15, 669–678 (2016).
Lai, B. F. L., Davenport Huyer, L., Lu, R. X. Z., Drecun, S. & Radisic, M. InVADE: integrated vasculature for assessing dynamic events. Adv. Funct. Mater. 27, 1703524 (2017).
Sung, J. H., Kam, C. & Shuler, M. L. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 10, 446–455 (2010).
Trietsch, S. J., Israels, G. D., Joore, J., Hankemeier, T. & Vulto, P. Microfluidic titer plate for stratified 3D cell culture. Lab Chip 13, 3548–3554 (2013).
Trietsch, S. J. et al. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nat. Commun. 8, 262 (2017).
Wang, Y. I. & Shuler, M. L. UniChip enables long-term recirculating unidirectional perfusion with gravity-driven flow for microphysiological systems. Lab Chip 18, 2563–2574 (2018).
Zhang, B. et al. Microfabrication of AngioChip, a biodegradable polymer scaffold with microfluidic vasculature. Nat. Protoc. 13, 1793–1813 (2018).
Davenport Huyer, L. et al. Highly elastic and moldable polyester biomaterial for cardiac tissue engineering applications. ACS Biomater. Sci. Eng. 2, 780–788 (2016).
Zhang, B. & Radisic, M. Organ-on-a-chip devices advance to market. Lab Chip 17, 2395–2420 (2017).
Frey, O., Misun, P. M., Fluri, D. A., Hengstler, J. G. & Hierlemann, A. Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis. Nat. Commun. 5, 4250 (2014).
Schimek, K. et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip 13, 3588–3598 (2013).
Oleaga, C. et al. Multi-organ toxicity demonstration in a functioal human in vitro system composed of four organs. Sci. Rep. 6, 20030 (2016).
Miller, P. G. & Shuler, M. L. Design and demonstration of a pumpless 14 compartment microphysiological system. Biotechnol. Bioeng. 113, 2213–2227 (2016).
Zhang, Y. S. et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc. Natl Acad. Sci. USA 114, E2293–E2302 (2017).
Edington, C. D. et al. Interconnected microphysiological systems for quantitative biology and pharmacology studies. Sci. Rep. 8, 4530 (2018).
Park, D. Y., Lee, J., Chung, J. J., Jung, Y. & Kim, S. H. Integrating organs-on-chips: multiplexing, scaling, vasculatization and innnervation. Trends Biotechnol. 38, 99–112 (2020).
Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162–175 (2013).
Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
Lai, B. F. L. et al. Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ-on-a-chip vasculature. Adv. Funct. Mater. 30, 2000545 (2020).
Caggiati, A., Phillips, M., Lametschwandtner, A. & Allegra, C. Valves in small veins and venules. Eur. J. Vasc. Endovasc. Surg. 32, 447–452 (2006).
dela Paz, N. G. & D’Amore, P. A. Arterial versus venous endothelial cells. Cell Tissue Res. 335, 5–16 (2009).
Adamson, R. H., Huxley, V. H. & Curry, F.-R. E. Single capillary permeability to proteins having similar size but different charge. Am. J. Physiol. Heart Circ. Physiol. 254, H304–H312 (1988).
Curry, F.-R. E. & Adamson, R. H. Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiol. Res. 87, 218–229 (2010).
Chiu, L. L., Montgomery, M., Liang, Y., Liu, H. & Radisic, M. Perfusable branching microvessel bed for vascularization of engineered tissues. Proc. Natl Acad. Sci. USA 109, E3414–E3423 (2012).
Salcedo, R. et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1α. Am. J. Pathol. 154, 1125–1135 (1999).
Betz, C., Lenard, A., Belting, H. G. & Affolter, M. Cell behaviors and dynamics during angiogenesis. Development 143, 2249–2260 (2016).
Yeon, J. H., Ryu, H. R., Chung, M., Hu, Q. P. & Jeon, N. L. In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. Lab Chip 12, 2815–2822 (2012).
Oh, S. et al. “Open-top” microfluidic device for in vitro three-dimensional capillary beds. Lab Chip 17, 3405–3414 (2017).
Hsu, Y.-H., Moya, M. L., Hughes, C. C. W., George, S. C. & Lee, A. P. A microfluidic platform for generating large-scale nearly identical human microphysiological vascularized tissue arrays. Lab Chip 13, 2990–2998 (2013).
Jeon, J. S. et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc. Natl Acad. Sci. USA 112, 214–219 (2015).
Phan, D. T. T. et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Lab Chip 17, 511–520 (2017).
Lin, D. S. Y., Rajasekar, S., Marway, M. K. & Zhang, B. From model system to therapy: scalable production of perfusable vascularized liver spheroids in “open-top“ 384-well plate. ACS Biomater. Sci. Eng. https://doi.org/10.1021/acsbiomaterials.0c00236 (2020).
Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913–927.e18 (2019).
Acknowledgements
This work was funded by the Canadian Institutes of Health Research (CIHR) Operating Grants (MOP-126027, MOP-137107 and MOP-142382), Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN 326982-10), NSERC-CIHR Collaborative Health Research Grant (CHRP 493737-16), CIHR Foundation Grant (FDN-167274) and National Institutes of Health Grant 2R01 HL076485. M.R. was supported by a Canada Research Chair and Killam Fellowship, B.F.L.L. and R.X.Z.L. were supported by a NSERC Postgraduate Fellowship and L.D.H. was supported by a CIHR Vanier Scholarship.
Author information
Authors and Affiliations
Contributions
B.F.L.L., B.Z. and M.R. designed the research. B.F.L.L. and L.D.H. performed the research. B.F.L.L. analyzed the data. B.F.L.L., S.K., L.D.H. and R.X.Z.L prepared the figures. B.F.L.L., R.X.Z.L. and J.Y. prepared the supplementary videos. B.F.L.L., L.D.H. and M.R. wrote and edited the manuscript. B.F.L.L. and E.Y.W. prepared the fluorescent images. Q.W. provided the induced-pluripotent stem cell–derived cardiomyocytes for cardiac tissue engineering.
Corresponding author
Ethics declarations
Competing interests
M.R. and B.Z. are among the co-founders of TARA Biosystems, and they hold equity in this company. The AngioTube bioscaffold is licensed to TARA Biosystems. The remaining authors declare no competing interests.
Additional information
Peer review information Nature Protocols thanks Christopher C. W. Hughes, Noo Li Jeon and Ibrahim Tarik Ozbolat for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Key references using this protocol
Lai, B. F. L. et al. Adv. Funct. Mat. 27, 1703524 (2017): https://doi.org/10.1002/adfm.201703524
Lai, B. F. L. et al. Adv. Funct. Mat. 30, 2000545 (2020): https://doi.org/10.1002/adfm.202000545
Lu, R. X. Z. et al. Adv. Mat. Tech. (2020): https://doi.org/10.1002/admt.202000726
Supplementary information
Supplementary Information
Supplementary Figs. 1–5 and Supplementary Text 1.
Supplementary Video 1
Preparation of AngioTube scaffolds before the cleanroom.
Supplementary Video 2
Assembling AngioTube scaffolds with 3D stamping.
Supplementary Video 3
Hot-embossing of InVADE base plates.
Supplementary Video 4
Assembling InVADE plates.
Supplementary Video 5
Endothelialization of the AngioTube scaffold lumen on the InVADE platform.
Supplementary Video 6
Tracking cancer metastasis on a duo-organ model of the InVADE platform.
Supplementary Video 7
Perfusion of 1-µm FITC beads in the InVADE platform.
Supplementary Data 1
Photomasks for soft lithography microfabrication.
Source data
Source Data Fig. 2
Excel data for the stress-strain curve of the 2:3 version of the 1,2,4 polymer.
Rights and permissions
About this article
Cite this article
Lai, B.F.L., Lu, R.X.Z., Davenport Huyer, L. et al. A well plate–based multiplexed platform for incorporation of organoids into an organ-on-a-chip system with a perfusable vasculature. Nat Protoc 16, 2158–2189 (2021). https://doi.org/10.1038/s41596-020-00490-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41596-020-00490-1
This article is cited by
-
Microfluidic high-throughput 3D cell culture
Nature Reviews Bioengineering (2024)
-
Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications
Molecular Biology Reports (2024)
-
Human disease models in drug development
Nature Reviews Bioengineering (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.